PGP and neoplasm: In tumor cells, S. chinensis bioactive compounds can reverse multidrug resistance dependent on P-glycoprotein (Pgp-MDR) [28] and sensitize tumor cells to antitumor treatments, e.g., with doxorubicin [29,30].